Medvantx Inc, a provider of ecommerce and final mile delivery solutions, has named Jeremy V Gross as its new chief technology officer, it was reported yesterday.
In the new role, Gross will focus on the further development of the company's proprietary ecommerce, pharmacy and final mile delivery platform. As CTO, Gross will lead Medvantx's newly created business unit dedicated to advancing the company's technology platform, and identify new technology-based solutions for the company's clients.
Gross has a track record of over 30 years leading development teams and leveraging emerging technologies to create disruptive innovation within biopharma, healthcare and the financial technology industries. Earlier, he held senior technology, innovation and incubation leadership roles at Amgen, McKesson, Intuit and JPMorgan. Gross has lead the design, development and commercialisation of e-commerce, complex back-end logistics systems and cloud-based data solutions for pharmaceutical and global distribution companies, and early online banking and e-Commerce platforms in financial services.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer